Patent · US Active

Polymorphs of ARRY-380, a selective HER2 inhibitor and pharmaceutical compositions containing them

US10765678B2 · kind B2 · utility

4Cited by

12References

19Claims

0Family size

Assignee

Array BioPharma, Inc. · US

Inventors

Donald T. Corson · Boulder, US
Christopher M. Lindemann · Fort Collins, US
Daniel J. Watson · Lafayette, US

Key dates

Filing date	Oct 24, 2018
Grant date	Sep 8, 2020
Priority date	—
Expiry date	Oct 24, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Polymorphs of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine are provided herein. Processes for preparing the polymorphs and pharmaceutical composition comprising the polymorphs are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.